Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease
暂无分享,去创建一个
[1] A. Moss,et al. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). , 2016, Heart rhythm.
[2] I. van der Tweel,et al. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study). , 2016, The American journal of cardiology.
[3] J. Brachmann,et al. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study , 2015, Clinical Research in Cardiology.
[4] A. Auricchio,et al. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. , 2015, Heart rhythm.
[5] S. Etheridge,et al. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies. , 2015, Heart rhythm.
[6] D. Babuty,et al. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. , 2014, JACC. Heart failure.
[7] K. Gauvreau,et al. Time Dependence of Risks and Benefits in Pediatric Primary Prevention Implantable Cardioverter-Defibrillator Therapy , 2014, Circulation. Arrhythmia and electrophysiology.
[8] K. Gauvreau,et al. Psychiatric Functioning and Quality of Life in Young Patients With Cardiac Rhythm Devices , 2014, Pediatrics.
[9] C. Berul,et al. Multi-Institutional Study of Implantable Defibrillator Lead Performance in Children and Young Adults: Results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) Study , 2013, Circulation.
[10] A. Proclemer,et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. , 2013, JAMA.
[11] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[12] P. Kannankeril,et al. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients. , 2012, Heart rhythm.
[13] M. Schalij,et al. Update on Small‐Diameter Implantable Cardioverter‐Defibrillator Leads Performance , 2012, Pacing and clinical electrophysiology : PACE.
[14] S. Saba,et al. Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[15] Andrew S. Mugglin,et al. Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure: Implications for Patient Management , 2011, Circulation.
[16] M. Gollob,et al. Psychological Adjustment in ICD Patients Living With Advisory Fidelis Leads , 2011, Journal of cardiovascular electrophysiology.
[17] D. Atkins,et al. Multicenter Study of the Effectiveness of Implantable Cardioverter Defibrillators in Children and Young Adults With Heart Disease , 2011, Pediatric Cardiology.
[18] A. Elvan,et al. Characteristics of Sprint Fidelis lead failure. , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[19] I. Law,et al. Inappropriate ICD Discharges in Single‐Chamber Versus Dual‐Chamber Devices in the Pediatric and Young Adult Population , 2009, Journal of cardiovascular electrophysiology.
[20] M. Gollob,et al. Accelerating risk of Fidelis lead fracture. , 2008, Heart rhythm.
[21] Stephen L Moore,et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.
[22] Wojciech Zareba,et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.
[23] L. F. Moreira,et al. Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator. , 2007, Arquivos brasileiros de cardiologia.
[24] B. Zrenner,et al. Implantable cardioverter defibrillator (ICD) in children. , 2006, International journal of cardiology.
[25] N. Blom,et al. Implantable cardioverter defibrillator implantation in children in The Netherlands , 2005, European Journal of Pediatrics.
[26] Michael O. Sweeney,et al. Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.
[27] P. Coumel,et al. Death Due to an Implantable Cardioverter Defibrillator , 2004, Journal of cardiovascular electrophysiology.
[28] T. Paul,et al. High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter Defibrillator , 2004, Pacing and clinical electrophysiology : PACE.
[29] A. Russo,et al. Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks , 2003, Circulation.